Categories: AlphaGraphs

Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell.

The revenue increased by 16% to $6.4 billion compared to the previous year.

The net income was $1.72 billion or $1.37 per share compared to $1.55 billion or $1.22 per share of the same quarter in the previous year.

The adjusted earnings per share were $2.08 compared to $1.68 of the previous year.

Recent Posts

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

10 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

12 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

36 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

51 minutes ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

58 minutes ago

Harley-Davidson Q4 2025 Results Reflect Margin Pressure

Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…

1 hour ago